Rani Therapeutics Holdings, Inc. (RANI)
0.8527
+0.01
(+1.51%)
USD |
NASDAQ |
Aug 31, 13:15
Rani Therapeutics Holdings Total Liabilities (Quarterly) : 12.86M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.86M |
| March 31, 2026 | 16.34M |
| December 31, 2025 | 17.11M |
| September 30, 2025 | 22.11M |
| June 30, 2025 | 26.05M |
| March 31, 2025 | 29.47M |
| December 31, 2024 | 33.14M |
| September 30, 2024 | 37.76M |
| June 30, 2024 | 38.18M |
| March 31, 2024 | 38.98M |
| December 31, 2023 | 32.47M |
| Date | Value |
|---|---|
| September 30, 2023 | 35.62M |
| June 30, 2023 | 35.34M |
| March 31, 2023 | 34.86M |
| December 31, 2022 | 34.02M |
| September 30, 2022 | 21.60M |
| June 30, 2022 | 5.69M |
| March 31, 2022 | 4.665M |
| December 31, 2021 | 2.64M |
| September 30, 2021 | 5.25M |
| June 30, 2021 | 201.00M |
| March 31, 2021 | 200.55M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 3.605M |
| CNBX Pharmaceuticals, Inc. | 2.672M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 112.90M |
| Fulcrum Therapeutics, Inc. | 13.26M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 60.84M |
| Shareholders Equity (Quarterly) | 39.23M |
| Debt to Equity Ratio | 0.0905 |
| Current Ratio | 5.313 |
| Net Debt Paydown Yield | 5.17% |